Amniotic fluid embolism: A puzzling and dangerous obstetric problem

English version

Autoři: Sarka Lisonkova ^aff001; Michael S. Kramer ^aff002
Působiště autorů: Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, British Columbia, Canada ^aff001; Department of Pediatrics and of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada ^aff002
Vyšlo v časopise: Amniotic fluid embolism: A puzzling and dangerous obstetric problem. PLoS Med 16(11): e32767. doi:10.1371/journal.pmed.1002976
Kategorie: Perspective
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1002976

Souhrn

In a Perspective, Sarka Lisonkova and Michael Kramer discuss the accompanying study by Kathryn Fitzpatrick and co-authors on management of amniotic fluid embolism.

Klíčová slova:

Obstetrics and gynecology – Signs and symptoms – Pregnancy – Medical risk factors – Cardiac arrest – Amniotic fluid – Coagulopathy

Zdroje

1. Fitzpatrick KE, van den Akker T, Bloemenkamp KWM, Deneux-Tharaux C, Kristufkova A, Li Z. Risk factors, management, and outcomes of amniotic fluid embolism: A multicountry, population-based cohort and nested case-control study. PLoS Med. 2019;16(11):e1002962. https://doi.org/10.1371/journal.pmed.1002962

2. McDonnell NJ, Percival V, Peach MJ. Amniotic fluid embolism: a leading cause of maternal death yet still a medical conundrum. Int J Obstet Anesthesia 2013;22,329–36.

3. Knight M, Kurinczuk JJ, Tuffnell D, Brocklehurst P. The UK Obstetric Surveillance System for rare disorders of pregnancy. BJOG 2005;112(3):263–5. doi: 10.1111/j.1471-0528.2005.00609.x 15713136

4. Knight M. The International Network of Obstetric Survey Systems (INOSS): benefits of multi-country studies of severe and uncommon maternal morbidities. Acta Obstet Gynecol Scand 2014;93:127–31. doi: 10.1111/aogs.12316 24382256

5. Clark SL, Romero R, Dildy GA, Callaghan WM, Smiley RM, Bracey AW, et al. Proposed diagnostic criteria for the case definition of amniotic fluid embolism in research studies. Am J Obstet Gynecol 2016;215(4):408–12. doi: 10.1016/j.ajog.2016.06.037 27372270

6. Knight M, Berg C, Brocklehurst P, Kramer M, Lewis G, Oats J, et al. Amniotic fluid embolism incidence, risk factors and outcomes: a review and recommendations. BMC Pregnancy Childbirth 2012;12:7. doi: 10.1186/1471-2393-12-7 22325370

7. Abenhaim HA, Azoulay L, Kramer MS, Leduc L. Incidence and risk factors of amniotic fluid embolisms: a population-based study on 3 million births in the United States. Am J Obstet Gynecol 2008;199:49.e1–49.e8.

8. Fitzpatrick KE, Tuffnell D, Kurinczuk JJ, Knight M. Incidence, risk factors, management and outcomes of amniotic-fluid embolism: a population-based cohort and nested case-control study. BJOG 2016;123(1):100–9. doi: 10.1111/1471-0528.13300 25683758

9. Kramer MS, Rouleau J, Baskett TF, Joseph KS; Maternal Health Study Group of the Canadian Perinatal Surveillance System. Amniotic-fluid embolism and medical induction of labour: a retrospective, population-based cohort study. Lancet 2006;368:1444–8. doi: 10.1016/S0140-6736(06)69607-4 17055946

10. Clark SL, Hankins GDV, Dudley DA, Dildy GA, Porter TF. Amniotic fluid embolism: Analysis of the national registry. Am J Obstet Gynecol. 1995;172(4):1158–69.